EVALUTION®, MyCartis diagnostic platform, leverages high quality analytical performance from conventional immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real-time. This provides the user with novel, timely and hence highly actionable information.
Included in the Export Interest Directory? No
Business Needs: Investor, Joint Ventures, Licensing Agreements